CNTB
Price
$0.87
Change
-$0.01 (-1.14%)
Updated
Oct 9 closing price
Capitalization
68.01M
40 days until earnings call
Intraday BUY SELL Signals
CTNM
Price
$13.38
Change
+$0.20 (+1.52%)
Updated
Oct 9 closing price
Capitalization
478.92M
33 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CNTB vs CTNM

CNTB vs CTNM Comparison Chart in %
View a ticker or compare two or three
VS
CNTB vs. CTNM commentary
Oct 10, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNTB is a Hold and CTNM is a Buy.

Interact to see
Advertisement
SUMMARIES
Loading...
TECHNICAL ANALYSIS
Technical Analysis
CNTBCTNM
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
74%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
COMPARISON
Comparison
Oct 10, 2026
Stock price -- (CNTB: $0.88 vs. CTNM: $13.18)
Brand notoriety: CNTB and CTNM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNTB: 39% vs. CTNM: 227%
Market capitalization -- CNTB: $68.01M vs. CTNM: $478.92M
CNTB [@Biotechnology] is valued at $68.01M. CTNM’s [@Biotechnology] market capitalization is $478.92M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNTB’s FA Score shows that 1 FA rating(s) are green while CTNM’s FA Score has 1 green FA rating(s).

  • CNTB’s FA Score: 1 green, 4 red.
  • CTNM’s FA Score: 1 green, 4 red.
According to our system of comparison, CTNM is a better buy in the long-term than CNTB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNTB’s TA Score shows that 5 TA indicator(s) are bullish while CTNM’s TA Score has 5 bullish TA indicator(s).

  • CNTB’s TA Score: 5 bullish, 5 bearish.
  • CTNM’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both CNTB and CTNM are a good buy in the short-term.

Price Growth

CNTB (@Biotechnology) experienced а -10.11% price change this week, while CTNM (@Biotechnology) price change was +1.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.53%. For the same industry, the average monthly price growth was -13.44%, and the average quarterly price growth was -4.28%.

Reported Earning Dates

CNTB is expected to report earnings on Nov 18, 2026.

CTNM is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (-2.53% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
CNTB
Daily Signal:
Gain/Loss:
CTNM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WFCF13.990.54
+4.01%
Where Food Comes From
RBCAA92.350.46
+0.50%
Republic Bancorp
PNR52.300.11
+0.21%
Pentair plc
MVBF29.50-0.08
-0.27%
MVB Financial Corp
SATA98.82-0.60
-0.60%
Strive Inc

CNTB and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNTB has been loosely correlated with AMRN. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if CNTB jumps, then AMRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTB
1D Price
Change %
CNTB100%
-6.77%
AMRN - CNTB
55%
Loosely correlated
-0.25%
CTNM - CNTB
33%
Poorly correlated
+3.53%
ASMB - CNTB
31%
Poorly correlated
-0.57%
INKT - CNTB
31%
Poorly correlated
-3.15%
DNTH - CNTB
30%
Poorly correlated
-2.89%
More